Why the Starpharma Holdings Limited share price rocketed 10% higher today

The Starpharma Holdings Limited (ASX:SPL) share price has been a huge mover today. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In afternoon trade the Starpharma Holdings Limited (ASX: SPL) share price has been amongst the biggest movers on the market.

At the time of writing the dendrimer product developer's shares are up a massive 10.5% to 84 cents.

What happened?

This morning Starpharma announced promising results from its VivaGel BV phase 3 trials.

According to the release, the trials of the gel for the prevention of recurrent bacterial vaginosis (rBV) achieved their primary objective and demonstrated statistically significant superiority compared to a placebo.

In light of this, the company will now submit a marketing application to the FDA for the gel in relation to the treatment of rBV.

As there are currently no approved products for the prevention of rBV, management believes there is a significant unmet medical need.

Which is great news for shareholders because Starpharma's CEO Jackie Fairley estimates the market to be worth in excess of US$1 billion per annum globally.

Given that Starpharma's market capitalisation is approximately $310 million, VivaGel BV has the potential to be a game-changer for the company.

Should you invest?

Overall, I believe the potential of VivaGel BV makes the company well worth keeping a close eye on.

But it is early days and the company must now look to gain FDA approval, which can be a lengthy and costly endeavour.

So for now I would suggest investors keep Starpharma on their watchlist and consider gaining exposure to the sector through the likes of CSL Limited (ASX: CSL) or Bionomics Ltd (ASX: BNO) for the time being.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »